STEPHAN BRAUTIGAM: Open Payments
NPI 1215392550 · LAWRENCEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124 in 7 payments from 6 companies in 2025. Trend: 2023 $34 · 2024 $158 · 2025 $124
Food & beverage: $124
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $14 |
Products named: SPRAVATO, REXULTI, CAPLYTA, Subvenite, FANAPT, Quviviq.
Industry payments across NJ — which companies pay providers there.
